DRI and Foundation News

Press Releases     In the News     DRI tv     Publications     images & Video     D-Stats       

Diabetes Research Institute Elects Jericho Attorney Bruce A. Siegel to Serve on its National Board of Directors

Bruce A. SiegelJericho, NY (October 7, 2014) – The Diabetes Research Institute Foundation is pleased to announce that Bruce A. Siegel of New York, NY, has been elected to serve on its National Board of Directors.  He also serves as co-chairman of the organization’s Northeast Region Board, alongside Marc S. Goldfarb.  

“My commitment is to finding a cure for diabetes.  I have strongly aligned myself with this organization because I believe the Diabetes Research Institute is on the fastest pathway to a biological cure for diabetes,” said Siegel, who has a daughter, Sara, living with type 1 diabetes.

Siegel is Executive Vice President and General Counsel of First Long Island Investors, LLC (FLI), which recently celebrated its 30th anniversary as a boutique wealth management company in Jericho, NY.  He also serves as a member of FLI’s Investment Committee and has worked for the company since 1989.  His responsibilities include wealth management, estate planning, insurance evaluation and acquisition, and real estate advisory services.  He began his career as an attorney with the U.S. Securities and Exchange Commission.  He worked in private practice with a New York City law firm, was assistant general counsel for a public company, and managed the Partnership Review Group for Merrill Lynch Pierce Fenner and Smith.  Siegel was a senior vice president of W.P. Stewart Asset Management (N.A.) from 1998 to 2003.

Siegel previously served on the DRIF’s Long Island Region Board and as a member of its Executive Committee, as well as the organization’s National Planned Giving Committee.  Prior to that, he served as a volunteer in several capacities for more than 20 years for JDRF.  He graduated from Cornell University in 1970 and received a J.D. degree from New York University School of Law in 1974. He was admitted to the New York State Bar in 1975.

“Bruce Siegel has already proven his ability to lead since taking on the role of co-chair of our Northeast Board of Directors.  We are fortunate to have him now join our National Board of Directors,” said Harold G. Doran, Jr., National Board chairman.  “I know that his background, expertise and passion to find a cure will continue to be an asset to our organization.”

The national office of the Diabetes Research Institute Foundation is located at 200 South Park Road, Suite 100, Hollywood, FL, 33021.  Two regional offices operate as part of the organization’s Northeast Region.  The Jericho office, located at 410 Jericho Turnpike, Suite 201, Jericho, NY, 11753, can be reached at 516.822.1700.  The Manhattan office, located at 381 Park Avenue, South, Suite 1118, New York, NY, 10016, can be reached at 212.888.2217.   

About First Long Island Investors, LLC

First Long Island Investors, LLC is a wealth management firm overseeing more than $1.2 billion dollars in assets. Established in 1983, the company provides a practical and transparent range of investment and wealth management solutions for a select group of high net-worth individuals, families, and select institutions drawn primarily from the metropolitan New York area. For decades, its principals, officers and employees continue to invest side-by-side with its clients, excluding fixed income which is customized for each client. More information can be found at www.fliinvestors.com

About the Diabetes Research Institute and Foundation

The Diabetes Research Institute Foundation is the organization of choice for those who are serious, passionate and committed to curing diabetes. Its mission – to provide the Diabetes Research Institute with the funding necessary to cure diabetes now – is a testament to the belief that tomorrow is not soon enough to cure those living with diabetes.

The Diabetes Research Institute at the University of Miami Miller School of Medicine leads the world in cure-focused research. As the largest and most comprehensive research center dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure by restoring natural insulin production and normalizing blood sugar levels without imposing other risks. Researchers have already shown that diabetes can be reversed through islet transplantation, with some study patients living without the need for insulin injections for more than a decade. The Institute is now building upon these promising outcomes by developing the DRI BioHub, an integrated “mini organ” that mimics the native pancreas, containing thousands of insulin-producing cells that sense blood sugar levels and produce the precise amount of insulin needed in real time.  The Diabetes Research Institute and Foundation were created for one reason – to cure diabetes – which is and will continue to be its singular focus until that goal is reached. For the millions of children and adults affected by diabetes, the Diabetes Research Institute is the best hope for a cure.

For more information, contact 1-800-321-3437, info@drif.org or visit DiabetesResearch.org.

# # #

Media Contact:
Lauren Schreier
lschreier@drif.org

Keep up with our progress toward a cure & more

Be a DRI Insider - Get News!

Media Contacts:

Lauren Schreier
Sr. Director, Marketing & Comm
954.964.4040

Lori Weintraub, APR
Senior VP, Marketing & Comm
954.964.4040

Mitra Zehtab, MD, MBA
COO 
305.243.9537


Press Release Archive

2016 | 2017 | 2018  

2011 | 2012 | 2013 | 2014 | 2015 

2006 | 2007 | 2008 | 2009 | 2010 

1998 - 2002 | 2003 - 2005